Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles

Published:2006-01 Issue:1 Volume:117 Page:78-88
ISSN:0019-2805
Container-title:Immunology
language:en
Short-container-title:Immunology

Author:

Shen Hong,Ackerman Anne L.,Cody Virginia,Giodini Alessandra,Hinson Ella R.,Cresswell Peter,Edelson Richard L.,Saltzman W. Mark,Hanlon Douglas J.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2567.2005.02268.x/fullpdf

Reference62 articles.

1. Mechanisms of Exogenous Antigen Presentation by MHC Class I Molecules in Vitro and in Vivo: Implications for Generating CD8+ T Cell Responses to Infectious Agents, Tumors, Transplants, and Vaccines

2. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.

3. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens

4. Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens

5. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen

Cited by 362 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances on the application of nanobiomimetic structures as drug delivery systems;Journal of Drug Delivery Science and Technology;2024-10

2. PEI‐Engineered Lipid@PLGA Hybrid Nanoparticles for Multimodal Delivery of Antigens and Immune Adjuvants to the Respiratory Mucosa;Advanced Healthcare Materials;2024-09-11

3. Glucosylated Nanovaccines for Dendritic Cell-Targeted Antigen Delivery and Amplified Cancer Immunotherapy;ACS Nano;2024-08-28

4. A scaffold vaccine to promote tumor antigen cross-presentation via sustained toll-like receptor-2 (TLR2) activation;Bioactive Materials;2024-07

5. Multifunctional Nanomaterials: Recent Advancements in Cancer Therapeutics and Vaccines;Indian Journal of Microbiology;2024-05-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3